Evidence map›Paper›PMID 39237105›Full record

ArticleJournal of chemical information and modeling2024

Drug-Target Interactions Prediction at Scale: The Komet Algorithm with the LCIdb Dataset.

Gwenn Guichaoua, Philippe Pinel, Brice Hoffmann, Chloé-Agathe Azencott, Véronique Stoven

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gwenn GuichaouaCenter for Computational Biology (CBIO), Mines Paris-PSL, 75006 Paris, France.ORCID 0009-0009-4225-4643
Philippe PinelCenter for Computational Biology (CBIO), Mines Paris-PSL, 75006 Paris, France.ORCID 0000-0002-6010-1853
Brice HoffmannIktos SAS, 75017 Paris, France.ORCID 0000-0003-1703-7099
Chloé-Agathe AzencottCenter for Computational Biology (CBIO), Mines Paris-PSL, 75006 Paris, France.ORCID 0000-0003-1003-301X
Véronique StovenCenter for Computational Biology (CBIO), Mines Paris-PSL, 75006 Paris, France.ORCID 0000-0003-0828-0759

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-target interactions (DTIs) prediction algorithms are used at various stages of the drug discovery process. In this context, specific problems such as deorphanization of a new therapeutic target or target identification of a drug candidate arising from phenotypic screens require large-scale predictions across the protein and molecule spaces. DTI prediction heavily relies on supervised learning algorithms that use known DTIs to learn associations between molecule and protein features, allowing for the prediction of new interactions based on learned patterns. The algorithms must be broadly applicable to enable reliable predictions, even in regions of the protein or molecule spaces where data may be scarce. In this paper, we address two key challenges to fulfill these goals: building large, high-quality training datasets and designing prediction methods that can scale, in order to be trained on such large datasets. First, we introduce LCIdb, a curated, large-sized dataset of DTIs, offering extensive coverage of both the molecule and druggable protein spaces. Notably, LCIdb contains a much higher number of molecules than publicly available benchmarks, expanding coverage of the molecule space. Second, we propose Komet (Kronecker Optimized METhod), a DTI prediction pipeline designed for scalability without compromising performance. Komet leverages a three-step framework, incorporating efficient computation choices tailored for large datasets and involving the Nyström approximation. Specifically, Komet employs a Kronecker interaction module for (molecule, protein) pairs, which efficiently captures determinants in DTIs, and whose structure allows for reduced computational complexity and quasi-Newton optimization, ensuring that the model can handle large training sets, without compromising on performance. Our method is implemented in open-source software, leveraging GPU parallel computation for efficiency. We demonstrate the interest of our pipeline on various datasets, showing that Komet displays superior scalability and prediction performance compared to state-of-the-art deep learning approaches. Additionally, we illustrate the generalization properties of Komet by showing its performance on an external dataset, and on the publicly available

Indexed as

AlgorithmsDrug DiscoveryProteinsPharmaceutical PreparationsPharmaceutical PreparationsProteins

Identifiers

PMID39237105
PMCPMC11423346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.